Literature DB >> 7648723

Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes.

T Takizawa1, S Nishinarita, N Kitamura, J Hayakawa, H Kang, Y Tomita, K Mitamura, K Yamagami, T Horie.   

Abstract

The effect of fibronectin on IL-1 alpha, IL-1 beta, tumour necrosis factor-alpha (TNF-alpha), and IL-6 production was investigated with cultured monocytes isolated from human peripheral blood. Monokine concentrations were determined by both ELISA and bioassay. Fibronectin markedly stimulated the secretion of IL-1 alpha, IL-1 beta, TNF-alpha and IL-6 from cultured monocytes in a dose-dependent manner, with the maximal effect apparent within 24 h. Northern blot analysis revealed a marked increase in the abundance of mRNA specific for each monokine on exposure of monocytes to fibronectin. Monoclonal antibodies to the alpha chain of very late antigen (VLA)-5, the beta 1 integrin, the alpha chain of Mac-1, and the beta 2 integrin, as well as the synthetic peptide of GRGDSP (which corresponds to the cell-binding domain of fibronectin), inhibited (> 50%) fibronectin-induced monokine production. Monoclonal antibodies to the alpha chain of VLA-4, and the alpha chain of LFA-1, as well as the synthetic peptide CS-1 (which corresponds to the alternatively spliced connecting segment of fibronectin) and the control peptide GRADSP, had no inhibitory effect on monokine production. A MoAb, R60, that recognizes an epitope of the fibronectin molecule that includes the RGD sequence, inhibited monokine production, whereas the MoAb Y16, which recognizes another epitope of fibronectin not including RGD, did not. These results indicate that fibronectin-induced production of IL-1 alpha, IL-1 beta, TNF-alpha and IL-6 from cultured monocytes is mediated predominantly by interaction of the cell-binding domain of fibronectin with VLA-5, although Mac-1 also may contribute to this effect of fibronectin. Our results indicate that the interaction of fibronectin with integrins may contribute to the cytokine network in inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648723      PMCID: PMC1553268          DOI: 10.1111/j.1365-2249.1995.tb08367.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  59 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

Review 2.  Fibronectins--adhesive glycoproteins of cell surface and blood.

Authors:  K M Yamada; K Olden
Journal:  Nature       Date:  1978-09-21       Impact factor: 49.962

3.  Very late antigen-5 and complement receptor type 3 cooperatively mediate the interaction between Bordetella pertussis and human monocytes.

Authors:  W L Hazenbos; B M van den Berg; R van Furth
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

4.  Fibronectin.

Authors:  D F Mosher
Journal:  Prog Hemost Thromb       Date:  1980

Review 5.  The structure and biologic activities of plasma fibronectin.

Authors:  M W Mosesson; D L Amrani
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

6.  Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.

Authors:  S Carsons; M W Mosesson; H S Diamond
Journal:  Arthritis Rheum       Date:  1981-10

7.  Significance of fibronectin in rheumatoid arthritis and osteoarthrosis.

Authors:  D L Scott; A C Wainwright; K W Walton; N Williamson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

8.  Divalent cation modulation of fibronectin binding to heparin and to DNA.

Authors:  M Hayashi; K M Yamada
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Fibronectin is produced by human macrophages.

Authors:  K Alitalo; T Hovi; A Vaheri
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  6 in total

1.  Augmentation of recombinant CH50 polypeptide on the function of macrophages of mice during chemotherapy.

Authors:  G Zhang; Z Feng; D Li; H Cao; H Zhang
Journal:  J Tongji Med Univ       Date:  2000

Review 2.  Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.

Authors:  Douglas D Taylor; Cicek Gercel-Taylor
Journal:  Semin Immunopathol       Date:  2011-06-19       Impact factor: 9.623

3.  Cultured human monocytes secrete fibronectin in response to activation by proinflammatory cytokines.

Authors:  N Kitamura; S Nishinarita; T Takizawa; Y Tomita; T Horie
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

4.  Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations.

Authors:  Elio Schouppe; Patrick De Baetselier; Jo A Van Ginderachter; Adelaida Sarukhan
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

5.  Latent effects of fibronectin, alpha5beta1 integrin, alphaVbeta5 integrin and the cytoskeleton regulate pancreatic carcinoma cell IL-8 secretion.

Authors:  A G Lowrie; D M Salter; J A Ross
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

6.  Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes.

Authors:  Julie Sahler; Collynn F Woeller; Richard P Phipps
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.